Terapias Avanzadas para Tumores Sólidos Pediátricos
![Foto de Terapias Avanzadas para Tumores Sólidos Pediátricos](/img/uploaded/b208e5bd76d11417a3039a0beab16391.jpg)
![Foto de NavarraBiomed](/img/noimage_org.png)
NavarraBiomed
Pamplona, EspañaPublications in collaboration with researchers from NavarraBiomed (1)
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1